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Edited by Michael R. BubbAbstract We used four antibodies to regions of obscurin iso-
forms A and B, encoded by the obscurin gene, to investigate
the location of these proteins in skeletal myofibers at resting
and stretched lengths. Obscurin A (800 kDa) which was recog-
nized by antibodies generated to the N-terminal, Rho-GEF, and
the non-modular C-terminal domain that lacks the kinase-like
domains, localizes at the level of the M-band. Obscurin B
(900 kDa) which has the N-terminal, Rho-GEF, and the C-ter-
minal kinase-like domains, localizes at the level of the A/I junc-
tion. Additional isoforms, which lack one or more of these
epitopes, are present at the Z-disk and Z/I junction.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Obscurin is a recently discovered giant (800–900 kDa) pro-
tein of striated muscle that has many Ig and several FnIII do-
mains, as well as IQ, Src homology 3 (SH3), Rho guanine
nucleotide exchange factor and pleckstrin homology (Rho-
GEF/PH) domains, and can be alternatively spliced to produce
smaller products or to include kinase-like domains that may
function in signaling [1–6]. In longitudinal sections of adult
skeletal muscle, obscurin concentrated at the level of the Z-
disks and M-bands of sarcomeres [1,3,7–9], with one report
suggesting it repositioned into the I-band in stretched samples
[3] but the specific obscurin isoforms present at these sites were
not identified. In cross-sections of myofibers, labeling for
obscurin is in a reticular pattern, indicating that obscurin sur-
rounds the contractile apparatus [9], a position that distin-
guishes it from the two other giant proteins of the
sarcomere, titin and nebulin. Thus, products of the obscurin
gene may have unique roles in myofibrillogenesis.
Understanding the subcellular distribution of obscurin is
complicated by the presence of multiple alternatively spliced
forms. Obscurin is present in skeletal muscle in an 800 kDa
form, now termed obscurin A [4], characterized by a C-termi-
nal non-modular region that binds a small form of ankyrin in
the network sarcoplasmic reticulum [7,9]. An additional vari-*Corresponding author. Fax: +1 410 706 8341.
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the replacement, by alternative mRNA splicing, of the non-
modular carboxy terminus with two serine/threonine kinase-
like domains. Originally identified as the ‘‘giant kinase’’ iso-
form of obscurin [2,10,11] it has been more recently termed
obscurin B (Fig. 1) [4]. Obscurin is also expressed as several
smaller alternatively spliced variants [1,2,4,5,12]. Several alter-
natively spliced products have also been identified for obscu-
rin’s homologue in C. elegans, UNC-89 [13].
We used antibodies to different regions of obscurin, the N-
terminus, the C-terminus, the Rho-GEF domain, and the Ig
domain N-terminal to the first kinase-like domain (Ob68) to
characterize the subcellular location of some of the alterna-
tively spliced forms of obscurin in skeletal muscle at resting
length and after stretch (Fig. 1). We localized obscurin A
and obscurin B to the M-bands. In addition, we found obscu-
rin B near the A/I junction, and localized distinct obscurin do-
mains, or combinations thereof, likely to be indicative of other
alternatively spliced forms, to the Z-disk and at the Z/I junc-
tion. The presence of two and possibly more different forms
of obscurin at distinct sarcomeric locations suggests that these
proteins play several distinct roles in organizing and stabilizing
the contractile apparatus and nearby structures.2. Materials and methods
2.1. Antibodies
We used the reverse transcriptase polymerase chain reaction (rtPCR)
to amplify the coding region of the Rho-GEF domain of obscurin from
rat skeletal muscle poly A+ RNA (Clontech, Palo Alto, CA) using
the Superscript First Strand Synthesis System (Invitrogen, Carlsbad,
CA). The primers were: reverse transcriptase, GCCACA-
GATCTGCTTCACCCA; forward, AGTGAATTCGTCATCCAG-
GAGTTGCTGAGTTC; reverse, ATCGGATCCCTAGCGCTGTG-
GCAGGGCAGA. This cDNA was cloned into the EcoRI/XhoI sites
of pGEX-4T-1. Synthesis of the glutathione-S-transferase (GST)-
Rho-GEF protein was induced (0.3 mM IPTG, 4 h). The protein was
solubilized, purified and used to generate rabbit antibodies (Covance
Research Products, Denver, PA), as described [14,15]. Antibodies were
purified over affinity columns prepared with MBP-Rho-GEF. Immun-
odepletion experiments were performed by incubating 2 lg/ml of each
antibody with 200 lg/ml of the corresponding antigen in PBS/BSA/
NGS in a total volume of 1 mL (PBS containing 3% BSA, 10 mM
NaN3, 5% normal goat serum: Jackson ImmunoResearch Laborato-
ries, West Grove, PA) for 16 h at 4 C and using these pre-adsorbed
antibodies for immunolabeling.
We also used antibodies to: a-actinin (mouse IgG EA53, 1:400 dilu-
tion, Sigma Chemical Co., St. Louis, MO); mouse 9D10 to the PEVK
region of titin (supernatant fraction, used at 1:1 dilution, Developmen-
tal Studies Hybridoma Bank, Iowa City, IA); the N-terminal (Z-disk
region) epitopes of titin (titin-Z, 3 lg/ml; [12]); the N-terminal [12] and
C-terminal [9] regions of obscurin A; and the Ob68-serine-threonineblished by Elsevier B.V. All rights reserved.
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Fig. 1. Obscurin isoforms. Antibodies were prepared to distinct regions of obscurin: the N-terminal Ig domain, and the Rho-GEF domain, the non-
modular C-terminus of obscurin A and to Ob68, adjacent to the first kinase-like domain (SKII) in the giant kinase isoform, obscurin B.
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were generated in rabbits, except to the N-terminal domain of obscurin
and the 9D10 antibody to titin, which were created in mice.
Goat antibodies to mouse and rabbit IgGs, linked to Alexa-488 or
Alexa-568 (Molecular Probes, Eugene, OR), were diluted 1:200.
2.2. Immunoblotting
Homogenates of adult rat muscle EDL were prepared [17] and sup-
plemented with 50 U/mL benzonase (Novagen, Madison, WI). Ali-
quots (50 lg) were processed for SDS–PAGE and immunoblotting [5].
2.3. Stretched muscle
Extensor digitorum longus (EDL) muscles, removed from adult rats
with proximal and distal tendons intact, were placed in Krebs solution
equilibrated with 95% O2, and 5% CO2, pH 7.2. Silk threads (#4) were
tied around the tendons and muscles were extended to Lo, the resting
tension length in vitro from the proximal to the distal myotendinous
junction [18,19], or to distances ranging from 1.3 to 1.7 Lo. (Only smal-
ler bundles of fibers could be stretched to 1.7 Lo, due to the passive
resistance of the connective tissue in intact muscle). The muscles were
fixed immediately in 2% paraformaldehyde in PBS for 20 min, snap
frozen, and cryosectioned [9].
2.4. Fluorescent immunolabeling and confocal microscopy
Frozen longitudinal sections were incubated in PBS containing 3%
BSA and 5% non-immune goat serum (PBS/BSA/NGS) followed by pri-
mary antibodies in PBS/BSA/NGS overnight at 4 C [9]. Samples were
washed, incubated with species-specific secondary antibodies in PBS/
BSA/NGS, mounted in Vectashield, and observed with a Zeiss 410 con-
focal laser scanning microscope (Carl Zeiss, Inc., Tarrytown, NY).3. Results
3.1. Localization of obscurin epitopes in skeletal muscle at
resting sarcomere lengths
We used immunofluorescence to identify sites in resting mus-
cle fibers labeled by antibodies to different epitopes of obscu-rins A and B. The specificity of the C-terminal and SKII
antibodies have been previously described [5,9,16]. In addition,
we performed immunodepletion experiments demonstrating
that immunoreactivity was eliminated by preadsorbtion with
the immunogen (Fig. 2A, D, G, J, insets). Antibodies to the
N-terminus primarily recognize structures at the level of the
M-band, with additional but faint labeling near the Z-disk
(Fig. 2A), as determined by double immunofluorescence with
antibodies to epitopes of titin found at the Z-disk (Fig. 2B
and C). Double immunofluorescence experiments with anti-
bodies to a-actinin (Fig. 2E and F) indicate that the Rho-
GEF domain of obscurin is primarily found in structures at
the level of the M-band (Fig. 2D). As previously reported,
antibodies to the C-terminal region of obscurin A and to the
Ob68-serine-threonine kinase region of obscurin B (Fig. 2G
and J) recognize structures at both the Z-disk and M-band,
as determined by double immunofluorescence experiments
with antibodies to a-actinin (Fig. 2H, I; K, L ) [9,16]. These re-
sults suggest that both obscurin A and the epitopes within
Ob68 and its adjacent kinase-like domain, associated with
the B isoform, are present at the level of the M-band, though
the latter may be present at lower levels. Furthermore, an iso-
form of obscurin or a closely related protein that contains epi-
topes of the non-modular C-terminal domain of obscurin A is
likely to be present at the level of the Z-disk. However, we do
not discount the possibility that Rho-GEF and N-terminal epi-
topes are not as accessible at the Z-disk and this is an addi-
tional site of localization of obscurin A.3.2. Localization of obscurin epitopes in skeletal muscle at
stretched sarcomere lengths
Epitopes of obscurin that fail to label at particular sarco-
meric locations may be inaccessible. To increase accessibility,
Fig. 2. Localization of obscurin isoforms in muscle at resting length. (A–F) Double immufluorescence experiments with antibodies to Z-disk epitopes
of titin (B, C, red) and a-actinin (E, F, green) to mark Z-disks, and antibodies to the N-terminus (A, C, green) and Rho-GEF domain of obscurin (D,
F, red) show that the latter primarily label at the level of the M-band. (G–L) Similarly, with the two C-terminal antibodies, to the non-modular C-
terminal domain (G, I, red) and the SKII antibody to Ob68 (J, L, red). Both label primarily at the level of the Z-disk and M-band, identified by
comparison with a-actinin (H, I; K, L green). Immunodepletion experiments are shown in the lower left corners of the larger panels (A, D, G, J).
Average sarcomere lengths are indicated. Bars: 5 lm.
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(1.3–1.7 Lo) before immunolabeling with the same anti-obscu-
rin antibodies. Antibodies to the N-terminal and Rho-GEF
domains labeled stretched samples at the level of the M-band,
and also at the level of the I-band (Fig. 3A, D, G, J; compare
with labeling by antibodies to Z-disk epitopes of titin, Fig. 3B,
E, and a-actinin, Fig. 3H and K). Labeling at the I-band was
near the A/I junction, which also labeled with antibodies to the
PEVK region of titin (supplemental figure 1).
Antibodies to the non-modular C-terminus labeled both the
M-band and Z-disk in stretched samples, similar to un-
stretched muscle (Fig. 3M–O). Further increases in sarcomere
length to 3.6 lm did not further alter their labeling pattern,
although a slight splitting could be detected at the level of
the Z-disk (Fig. 3P), resulting in a decrease in overlap with
a-actinin (Fig. 3Q and R).
As in unstretched muscle, the SKII antibody that detects
obscurin B labeled the M-band and the periphery of the Z-
disk, near the Z/I junction, in stretched muscle. SKII antibod-
ies also labeled structures further into the I-band in stretchedmuscle, as described above with antibodies to the N-terminal
and Rho-GEF domains (Fig. 3S–X).
3.3. Relative protein levels of obscurin A and B
Using antibodies to the Rho-GEF domain, C-terminus and
N-terminus, we performed western blots on muscle extracts of
adult rat EDL. As expected, obscurin B has a greater molecu-
lar mass than obscurin A and is recognized by antibodies to
the Rho-GEF domain and the N-terminus, but not the C-ter-
minus. In addition, obscurin B appears to be present at signif-
icantly lower levels (Fig. 4).4. Discussion
Products of the obscurin gene play an important role in myo-
fibrillogenesis, especially in the assembly of the M-band
[16,17,20], but the functions of the various, alternatively spliced
gene products in this process are still unclear [1,2]. Our results
suggest that the two giant forms of obscurin, termed A and B,
Fig. 3. Localization of obscurin isoforms in stretched muscle. As in Fig. 2, but muscle was stretched to 1.3–1.7 Lo before immunolabeling. (A–F) In
addition to M-bands, antibodies to the N-terminus of obscurin label the I-band near the A/I junction (A, C, D, F; green; compared to titin at the Z-
disk: B, C, E, F; red). (G–L) Antibodies to the Rho-GEF domain also react with structures at both the M-band and A/I junction (G, I, J, L; red;
compared to a-actinin H, I, K, L; green). (M–R) The non-modular C-terminus of obscurin is at the level of the Z-disk and M-band (M, O; red;
compared to a-actinin: N, O; green) at 1.3 Lo. Greater stretching to 1.7 Lo produces splitting of the C-terminal antibody labeling of the Z-disk (P,
R; red; compared to a-actinin: Q, R; green). (S–X) Antibodies to Ob68 label at the level of the M-band and at two locations within the I-band, near
the A/I junction, and at the Z/I interface (S, U, V, X; red, compared to a-actinin: T, U, W, X; green). Average sarcomere lengths are indicated. Bars:
1 lm.
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Fig. 4. Immunoblotting of obscurins A and B. In immunoblots of
extracts of adult quadriceps, antibodies to the Rho-GEF domain of
obscurin and the N-terminal Ig domain recognize the 800 kDa isoform
(large arrow), likely to be obscurin A, and a larger isoform that is
present at much lower levels (small arrow), likely to be obscurin B.
Antibodies to the C-terminus of obscurin A recognize the obscurin A
isoform, but not the obscurin B isoform. Molecular masses are
indicated.
1552 A.L. Bowman et al. / FEBS Letters 581 (2007) 1549–1554are selectively enriched at different sites in skeletal muscle, and
that smaller alternatively spliced forms—or post-translation-
ally modified proteins—may be associated with the Z-disk
and nearby regions of the I-band. These results are the first
to document the differential distribution of different forms of
obscurin in mammalian striated muscle.
We previously studied the localization of obscurin with anti-
bodies to the non-modular C-terminus of obscurin A and deter-mined it to be at the level of Z- and M-lines in structures that
surround the contractile apparatus, where it may link the sarco-
plasmic reticulum to the contractile apparatus through binding
to small ankyrin 1 [7,9]. We subsequently created antibodies to
the N-terminal Ig, Rho-GEF, and Ob68 regions (Ob68 is adja-
cent to the first of two kinase-like domains of obscurin) and
localized their epitopes in skeletal muscle fibers of resting and
stretched lengths [3,5]. Obscurin A, as well as an epitope asso-
ciated with obscurin B, are present, at the M-band, as previ-
ously reported [1,7,9,16]. We find that obscurin B is also
present at the I-band near the A/I junction. We suggest further
that the isoform of obscurin present at the Z-disk that reacts
with antibodies to the non-modular C-terminus is a unique iso-
form which appears well after the formation of the Z-disk [11].
Our data suggest that this isoform may contain a novel N-ter-
minus and lack the Rho-GEF domain, although we cannot
now rule out the possibility that the non-modular C-terminus
is more accessible to antibodies, compared to other regions of
the molecule associated with the Z-disk. The SKII antibody,
to domains of obscurin B, labeled a form of the molecule in
the I-band near the periphery of the Z-disk. We also observed
this isoform to be recognized by antibodies to the second
kinase-like domain (link 7, data not shown). This is likely to
represent one of the smaller kinase-containing isoforms of
obscurin, some of which are known to be expressed at low levels
in skeletal muscle, but more studies of these splice forms will be
needed before they can be characterized and localized in the
myoplasm [2]. Whether this isoform may account for the label-
ing of the I-band by antibodies to Ob58/Ob59/Ob60 (formerly
referred to as I48/I49/I50), as previously described by Bang
et al. [3], remains to be determined. A summary of these iso-
forms and their sarcomeric locations is summarized in Fig. 5.
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Fig. 5. Schematic representation of localization of distinct obscurin
isoforms. The sarcomeric locations of each of the isoforms of obscurin
we have identified are indicated. An additional isoform that has not
been well characterized is likely to be located at the level of the Z-disk.
See text for discussion.
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forms of obscurin suggests that these proteins may have addi-
tional roles in myofibrillogenesis and muscle architecture that
remain to be discovered, in addition to their involvement in
the assembly of M- and A-bands or in the sarcomeric align-
ment of the SR [8,11,12,16,17]. The molecules of obscurin pres-
ent at the A/I junction are near or adjacent to the PEVK
region of titin, which serves as the principle elastic component
of the titin filament [21]. Thus, the form of obscurin present at
this site (obscurin B), may function to transduce stretch signals
from this region of titin. Experiments by Borisov et al. [10]
indicate that both obscurin Rho-GEF (obscurin A and B)
and kinase-encoding (obscurin B) transcripts are upregulated
after induction of hypertrophy, consistent with a role of obscu-
rin isoforms A and B in these cellular processes.
Our results suggest further that other proteins or protein epi-
topes in the I-band are ‘hidden’ and thus unable to react with
antibodies, and that stretching muscle may expose them, per-
haps by reducing local protein densities or altering local confor-
mations. Our findings may also indicate that some proteins
originally identified as being at the Z-disk may actually associ-
ate with nearby regions of the I-band [22]. Immunofluorescence
studies of stretched muscle can therefore provide a more com-
plete characterization of the location of sarcomeric proteins.
Acknowledgements: This work was supported by Grants from the Na-
tional Institutes of Health to R.J.B. (R01 HL64304), M.W.R (R01
HL075093), and A.K.K. (R01 AR52768).Appendix A. Supplementary data
Supplementary data associated with this article can be
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